Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapies for rare and serious liver diseases. As a subsidiary of Alfasigma, it leverages innovative research in liver health to improve patient outcomes globally.